Innovating Breast Cancer Treatments Through Targeted Molecular Therapy

Medical Oncology · Breast Cancer Research · Molecular Targeted Therapy · Clinical Trials

Madrid, Spain 6 services
Medical OncologyBreast Cancer ResearchMolecular Targeted TherapyClinical TrialsHematology
Breast Cancer TreatmentMolecular Targeted TherapyClinical ResearchOncology ConsultationCancer Clinical TrialsHematology Services
Development of Herceptin
Josep Baselga led the development of Herceptin, a groundbreaking monoclonal antibody for HER2-positive breast cancer.
Memorial Sloan Kettering Cancer Center
Leadership at Vall d'Hebron Institute
He served as the Director of the Vall d'Hebron Institute of Oncology, advancing cancer research and treatment.
Vall d'Hebron Institute of Oncology
Contributions to Hematology and Oncology
Baselga made significant contributions in both hematology and oncology at Massachusetts General Hospital.
Massachusetts General Hospital

No reviews yet. Be the first to leave one below.